摘要:
According to the present invention, it is possible to improve the blood retention capability by a carrier for delivering a nucleic acid such as siRNA. A unit structure-type pharmaceutical composition of the present invention contains a block copolymer having a cationic polyamino acid segment and a hydrophilic polymer chain segment and a nucleic acid; the composition is electrically neutral by counterbalancing negative charge (s) of the nucleic acid with positive charge(s) of the cationic polyamino acid segment, and the nucleic acid is covered with the hydrophilic polymer chain segment.
摘要:
The present invention provides a cationic polyamino acid suitable for a carrier that can form a stable complex with a nucleic acid under a physiological condition and release the nucleic acid in cells suitably. The cationic polyamino acid can associate with a nucleic acid and includes a cationic amino acid residue having a cationic group in a side chain and a hydrophobic amino acid residue having a hydrophobic group in a side chain. The cationic polyamino acid includes 1 to 20 units of the cationic amino acid residue and is represented by the following formula (1).
The meaning of each symbol in the formula is as shown in the description.
摘要:
The present invention provides a block copolymer as a carrier that simultaneously achieves stability of a biotechnology-based drug in blood and drug-releasing property of the drug at an affected area. The block copolymer of the present invention is a block copolymer, including: a polyamino acid chain segment; and a hydrophilic polymer chain segment, wherein the polyamino acid chain segment includes an amino acid residue having a cationic group in a side chain and an amino acid residue having a substituted phenylboronic acid group in a side chain, the substituted phenylboronic acid group having a phenyl ring in which at least one hydrogen atom is substituted to have a pKa around a physiological pH.
摘要:
The present invention provides a block copolymer applicable as a drug carrier capable of forming a stable complex with a nucleic acid and releasing the nucleic acid in cells. The block copolymer is represented by the following formula (1) or (2)
where: R 1 and R 2 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 12 carbon atoms which may have a substituent; A represents a hydrophilic polymer chain; L 1 and L 3 each represent a linking group; B represents a cation-containing group; R 3 represents a side chain of any appropriate amino acid; z represents an integer of 5 to 500; x represents an integer of 40% or more of z; y represents an integer and may represent 0; z-x-y represents an integer and may represent 0; p represents an integer of 1 to 10; and q represents an integer of 1 to 10.
摘要翻译:本发明提供了可用作能够与核酸形成稳定的复合物并在细胞中释放核酸的药物载体的嵌段共聚物。 嵌段共聚物由下式(1)或(2)表示,其中:R 1和R 2各自独立地表示氢原子或可具有取代基的碳原子数1〜12的直链或支链烷基; A表示亲水性聚合物链; L 1和L 3各自表示连接基团; B表示含阳离子基团; R 3表示任何合适的氨基酸的侧链; z表示5〜500的整数, x表示z的40%以上的整数。 y表示整数,可以表示0; z-x-y表示整数,可以表示0; p表示1〜10的整数, q表示1〜10的整数。
摘要:
The present invention provides a cationic polyamino acid suitable for a carrier that can form a stable complex with a nucleic acid under a physiological condition and release the nucleic acid in cells suitably. The cationic polyamino acid can associate with a nucleic acid and includes a cationic amino acid residue having a cationic group in a side chain and a hydrophobic amino acid residue having a hydrophobic group in a side chain. The cationic polyamino acid includes 1 to 20 units of the cationic amino acid residue and is represented by the following formula (1). The meaning of each symbol in the formula is as shown in the description.
摘要:
A liquid composition containing a polymer micelle and having a pH values of 3.0 to 7.0 is provided. The micelle is constituted of a coordination compound having a block copolymer of polyethylene glycol and polyglutamic acid and cisplatin that is coordinate-bonded to the block copolymer.
摘要:
It is intended to provide a method of effectively incorporating an inorganic fluorescent substance or an inorganic contrast medium into latex polymer particles to be used in a diagnostic test or the like and fluorescent substance-containing latex polymer particles thus produced which show reduced non-specific adsorption of protein, etc. Latex polymer particles are produced by subjecting a latex-forming monomer, a macromer containing at least a hydrophilic polymer segment and a fluorescent substance or an inorganic contrast medium, which simultaneously coexist together in an aqueous medium, to polymerization.